Trevi Therapeutics Inc (NASDAQ:TRVI)

2.48
Delayed Data
As of Jan 27
 +0.13 / +5.58%
Today’s Change
0.46
Today|||52-Week Range
4.68
+28.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeNet Revenues0.000.000.00----
Depreciation And Amortization4.0K4.0K23.0K--
 
 
 
 
 
Operating ExpensesGross Income-4.0K-4.0K-23.0K--
 
 
 
 
General Expenses8.6M8.2M18.4M--
 
 
 
 
Research And Development6.9M6.1M14.1M--
 
 
 
 
Total Operating Expenses8.6M8.2M18.4M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.6M-8.2M-18.4M--
 
 
 
 
Extraordinary Credit212.0K0.000.00--
 
 
Extraordinary Charge-76.0K-1.4M-2.2M--
 
 
 
 
Interest Expense On Debt2.6M3.3M174.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.1M-12.9M-20.7M--
 
 
 
 
Income Taxes-8.0K-26.0K-124.0K--
 
 
 
 
Preferred Dividend-4.4M-320.0K-5.0M--
 
 
 
 
Net Income-11.1M-12.9M-20.5M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.1M16.1M17.8M--
 
 
 
 
Shares To Calculate EPS Diluted16.1M16.1M17.8M--
 
 
 
 
 
Earnings Per ShareEPS-$0.42-$0.78-$1.44--
 
 
 
 
EPS Diluted-$0.42-$0.78-$1.44--